Overall, our results here demonstrated that pharmacological inhibition of C5a‐C5aR1 signaling, by using a C5aR1 antagonist, can rescue the excessive synaptic loss observed in the Tg2576 mouse model of AD. Here, C5AR1 is linked to Alzheimer disease.